Key points are not available for this paper at this time.
Although usually characterized by milder symptoms, ILE manifestations may require immunomodulatory treatments. Longitudinal studies are necessary to understand how ILE affects organ damage and future SLE risk, and to delineate molecular pathways unique to ILE.
Building similarity graph...
Analyzing shared references across papers
Loading...
Teresa Aberle
Rebecka L. Bourn
Melissa E. Munroe
Arthritis Care & Research
The University of Texas Southwestern Medical Center
Cincinnati Children's Hospital Medical Center
United States Department of Veterans Affairs
Building similarity graph...
Analyzing shared references across papers
Loading...
Aberle et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69da26750f778bd2e46844de — DOI: https://doi.org/10.1002/acr.23201
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: